ASX:Live
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Valuation
Value
Consensus
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
N/A
Address
Level 4 447 Collins Street Melbourne, Victoria (VIC) 3000
Description
Adherium Ltd. engages in the development, manufacture, and supply of digital health technologies. It operates through the following geographical segments: New Zealand and Australia, South-East Asian Countries, and Other Countries. The firm's Hailie system is transforming management of chronic respiratory conditions, especially asthma and chronic obstructive pulmonary disease. The company was founded by Garth Sutherland in 2001 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.02
Trade Value (12mth)
US$1,219.00
1 week
-16.67%
1 month
-16.67%
YTD
-58.33%
1 year
-67.59%
All time high
8.84
EPS 3 yr Growth
-88.50%
EBITDA Margin
%
Operating Cashflow
-$11m
Free Cash Flow Return
-134.80%
ROIC
-129.90%
Interest Coverage
-5,802.20
Quick Ratio
2.40
Shares on Issue (Fully Dilluted)
885m
HALO Sector
Healthcare
Next Company Report Date
27-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
NZD
Short Sell (% of issue)
0.00
| Date | Announcements |
|---|---|
|
03 July 25 |
Delay in Allotment of Securities Under ANREO Offer
×
Delay in Allotment of Securities Under ANREO Offer |
|
03 July 25 |
Application for quotation of securities - ADR
×
Application for quotation of securities - ADR |
|
03 July 25 |
Notification regarding unquoted securities - ADR
×
Notification regarding unquoted securities - ADR |
|
01 July 25 |
Update - Proposed issue of securities - ADR
×
Update - Proposed issue of securities - ADR |
|
01 July 25 |
Entitlement Offer Opens and Letters to Shareholders
×
Entitlement Offer Opens and Letters to Shareholders |
|
26 June 25 |
Successful Completion of Institutional Component of ANREO
×
Successful Completion of Institutional Component of ANREO |
|
26 June 25 |
Replacement Prospectus
×
Replacement Prospectus |
|
26 June 25 |
Update - Proposed issue of securities - ADR
×
Update - Proposed issue of securities - ADR |
|
25 June 25 |
Change in substantial holding
×
Change in substantial holding |
|
25 June 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
|
24 June 25 |
Trading Halt
×
Trading Halt |
|
24 June 25 |
Accel Non-Renounceable Entitlement Offer to raise up to $4m
×
Accel Non-Renounceable Entitlement Offer to raise up to $4m |
|
24 June 25 |
Prospectus
×
Prospectus |
|
24 June 25 |
Proposed issue of securities - ADR
×
Proposed issue of securities - ADR |
|
23 June 25 |
Application for quotation of securities - ADR
×
Application for quotation of securities - ADR |
|
23 June 25 |
Notification regarding unquoted securities - ADR
×
Notification regarding unquoted securities - ADR |
|
23 June 25 |
Change in substantial holding
×
Change in substantial holding |
|
23 June 25 |
Change in substantial holding
×
Change in substantial holding |
|
23 June 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
|
23 June 25 |
Update - Notification regarding unquoted securities - ADR
×
Update - Notification regarding unquoted securities - ADR |
|
28 May 25 |
Notification regarding unquoted securities - ADR
×
Notification regarding unquoted securities - ADR |
|
22 May 25 |
Change of Director's Interest Notice - G Baran
×
Change of Director's Interest Notice - G Baran |
|
20 May 25 |
Notification regarding unquoted securities - ADR
×
Notification regarding unquoted securities - ADR |
|
19 May 25 |
$900K Capital Raise to Accelerate Smart Inhaler in US
×
$900K Capital Raise to Accelerate Smart Inhaler in US |
|
19 May 25 |
Proposed issue of securities - ADR
×
Proposed issue of securities - ADR |
Load More
Load Less
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
.svg)
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.
